Bioactive Hexapeptide Reduced the Resistance of Ovarian Cancer Cells to DDP by Affecting HSF1/HSP70 Signaling Pathway

Ovarian cancer is the leading cause of death in gynecologic malignancies. Ovarian cancer as a metastatic malignant tumor is highly recurrent and prone to drug resistance. Bioactive peptides are an emerging area of biomedical research in reducing resistance of tumor cell to drugs. In this paper, we i...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ruowen, Xu, Qia, Liu, Liwei, Liu, Hui, Liu, Yun, Wei, Wenmei, Qin, Yide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425193/
https://www.ncbi.nlm.nih.gov/pubmed/34539881
http://dx.doi.org/10.7150/jca.62285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425193/
https://www.ncbi.nlm.nih.gov/pubmed/34539881
http://dx.doi.org/10.7150/jca.62285

Ejemplares similares